Etanercept (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Etanercept" in English language version.

refsWebsite

Global rank English rank

18nih.gov

4^th place

12doi.org

2^nd place

10web.archive.org

1^st place

9fda.gov

447^th place

338^th place

7europa.eu

68^th place

117^th place

3medicines.org.uk

3,823^rd place

2,387^th place

3semanticscholar.org

11^th place

8^th place

3gabionline.net

low place

2canada.ca

1,712^th place

1,063^rd place

2funnelback.com

low place

2tga.gov.au

3,984^th place

2,622^nd place

1hpfb-dgpsa.ca

low place

1drugs.com

399^th place

333^rd place

1hres.ca

low place

1dukemednews.org

low place

1handle.net

102^nd place

76^th place

1springer.com

274^th place

309^th place

1espacenet.com

800^th place

676^th place

1abovethelaw.com

low place

7,437^th place

1aan.com

low place

1cnn.com

28^th place

26^th place

1harvard.edu

18^th place

17^th place

1biopharmadive.com

low place

1sskrplaw.com

low place

1seattletimes.com

519^th place

316^th place

1nytimes.com

7^th place

1bostonherald.com

1,644^th place

917^th place

1archive.today

14^th place

1squarespace.com

2,953^rd place

1,823^rd place

1sec.gov

572^nd place

436^th place

1uspto.gov

1,459^th place

991^st place

1duke.edu

1,880^th place

1,218^th place

1cipla.com

low place

aan.com

"Practice Advisory: Etanercept for Poststroke Disability" (pdf). American Academy of Neurology. 6 June 2016.

abovethelaw.com

"Another Free Speech Win In Libel Lawsuit Disguised As A Trademark Complaint". Above the Law. 2017-02-24. Retrieved 2022-06-27.

archive.today

"Co-pay hike a painful reality; Miracle drug monthly cost jumps from $42 to $600" Archived 2013-01-18 at archive.today, Margery Eagan, Boston Herald, November 3, 2011

biopharmadive.com

Gardner J (November 1, 2021). "A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug".

bostonherald.com

"Co-pay hike a painful reality; Miracle drug monthly cost jumps from $42 to $600" Archived 2013-01-18 at archive.today, Margery Eagan, Boston Herald, November 3, 2011

canada.ca

"Health Canada New Drug Authorizations: 2016 Highlights". Health Canada. 14 March 2017. Retrieved 7 April 2024.
"Arthritis". Health Canada. 8 May 2018. Retrieved 13 April 2024.

cipla.com

"Cipla - Home" (PDF). Cipla.com. Archived from the original (PDF) on 2013-05-01. Retrieved 2019-06-05.

cnn.com

money.cnn.com

"Wyeth and Amgen heighten warning of life-threatening infections on skin drug Enbrel". Archived from the original on 2008-05-05. Retrieved 2008-05-02.

doi.org

Feldmann M, Maini RN (October 2003). "Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases". Nature Medicine. 9 (10): 1245–1250. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.
Peppel K, Crawford D, Beutler B (December 1991). "A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity". The Journal of Experimental Medicine. 174 (6): 1483–1489. doi:10.1084/jem.174.6.1483. PMC 2119031. PMID 1660525.
Peppel K, Poltorak A, Melhado I, Jirik F, Beutler B (November 1993). "Expression of a TNF inhibitor in transgenic mice". Journal of Immunology. 151 (10): 5699–5703. doi:10.4049/jimmunol.151.10.5699. PMID 7693816. S2CID 10859938.
Braun J, McHugh N, Singh A, Wajdula JS, Sato R (June 2007). "Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly". Rheumatology. 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.
Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. (April 2015). "TNF-alpha inhibitors for ankylosing spondylitis". The Cochrane Database of Systematic Reviews. 2015 (4): CD005468. doi:10.1002/14651858.CD005468.pub2. PMC 11200207. PMID 25887212.
Kim PJ, Lansang RP, Vender R (July 2023). "A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections". Journal of Cutaneous Medicine and Surgery. 27 (4): 358–367. doi:10.1177/12034754231188444. PMC 10486173. PMID 37533141.
Zalevsky J, Secher T, Ezhevsky SA, Janot L, Steed PM, O'Brien C, et al. (August 2007). "Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection". Journal of Immunology. 179 (3): 1872–1883. doi:10.4049/jimmunol.179.3.1872. PMID 17641054.
Madhusudan S, Muthuramalingam SR, Braybrooke JP, Wilner S, Kaur K, Han C, et al. (September 2005). "Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer". Journal of Clinical Oncology. 23 (25): 5950–5959. doi:10.1200/JCO.2005.04.127. PMID 16135466.
Houel S, Hilliard M, Yu YQ, McLoughlin N, Martin SM, Rudd PM, et al. (January 2014). "N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality". Analytical Chemistry. 86 (1): 576–584. doi:10.1021/ac402726h. PMID 24308717.
Mukai Y, Nakamura T, Yoshikawa M, Yoshioka Y, Tsunoda S, Nakagawa S, et al. (November 2010). "Solution of the structure of the TNF-TNFR2 complex". Science Signaling. 3 (148): ra83. doi:10.1126/scisignal.2000954. PMID 21081755. S2CID 24226117.
Lamanna WC, Mayer RE, Rupprechter A, Fuchs M, Higel F, Fritsch C, et al. (June 2017). "The structure-function relationship of disulfide bonds in etanercept". Scientific Reports. 7 (1): 3951. Bibcode:2017NatSR...7.3951L. doi:10.1038/s41598-017-04320-5. PMC 5479810. PMID 28638112.
Norman P (January 2017). "Enbrel and etanercept biosimilars: a tale of two patent systems". Pharmaceutical Patent Analyst. 6 (1): 5–7. doi:10.4155/ppa-2016-0043. PMID 28201948.

drugs.com

"Etanercept Use During Pregnancy". Drugs.com. 24 January 2020. Retrieved 13 August 2020.

duke.edu

scholarship.law.duke.edu

Kaldre I (2008). "The Future of Generic Biologics: Should the United States "Follow-On" the European Pathway?". www.law.duke.edu. Retrieved 2019-06-05.

dukemednews.org

"Arthritis Drug Effective for Depression in Psoriasis Sufferers". Archived from the original on 2007-10-20. Retrieved 2008-01-10.

espacenet.com

worldwide.espacenet.com

US 8900583, Tobinick EL, "Methods for treatment of brain injury utilizing biologics", published 2014-12-02

europa.eu

ema.europa.eu

"Nepexto EPAR". European Medicines Agency. 24 March 2020. Retrieved 4 March 2023.
"Enbrel EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 2 April 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Benepali EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 2 April 2020.
"Lifmior EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 2 April 2020.
"Public statement on Lifmior: Withdrawal of the marketing authorisation in the European Union" (PDF). Retrieved 2 April 2020.
"Erelzi EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 2 April 2020.

ec.europa.eu

"Nepexto Product information". Union Register of medicinal products. Retrieved 3 March 2023.

fda.gov

funnelback.com

tga-search.clients.funnelback.com

"Etera ARTG". Therapeutic Goods Administration (TGA). Archived from the original on 13 June 2021. Retrieved 12 June 2021.
"Rymti ARTG". Therapeutic Goods Administration (TGA). Archived from the original on 13 June 2021. Retrieved 12 June 2021.

gabionline.net

"New Amgen Enbrel patent could block biosimilars until 2028". 2011-11-25. Retrieved 2019-07-14.
"Japanese approval for Lupin's etanercept biosimilar".
"FDA approves etanercept biosimilar Eticovo". www.gabionline.net. Retrieved 2024-07-16.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

harvard.edu

ui.adsabs.harvard.edu

Lamanna WC, Mayer RE, Rupprechter A, Fuchs M, Higel F, Fritsch C, et al. (June 2017). "The structure-function relationship of disulfide bonds in etanercept". Scientific Reports. 7 (1): 3951. Bibcode:2017NatSR...7.3951L. doi:10.1038/s41598-017-04320-5. PMC 5479810. PMID 28638112.

hpfb-dgpsa.ca

dhpp.hpfb-dgpsa.ca

"Regulatory Decision Summary for Erelzi". Drug and Health Products Portal. 6 April 2017. Retrieved 13 April 2024.

hres.ca

hpr-rps.hres.ca

"Rymti Summary Basis of Decision". Health Canada. 23 October 2014. Archived from the original on 27 May 2023. Retrieved 10 March 2023.

medicines.org.uk

"Benepali 25 mg solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 25 January 2021. Retrieved 12 June 2021.
"Enbrel 25mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC)". (emc). 8 June 2021. Retrieved 12 June 2021.
"Erelzi 50 mg solution for injection in pre filled pen - Summary of Product Characteristics (SmPC)". (emc). 25 May 2021. Retrieved 12 June 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Feldmann M, Maini RN (October 2003). "Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases". Nature Medicine. 9 (10): 1245–1250. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.
Peppel K, Crawford D, Beutler B (December 1991). "A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity". The Journal of Experimental Medicine. 174 (6): 1483–1489. doi:10.1084/jem.174.6.1483. PMC 2119031. PMID 1660525.
Peppel K, Poltorak A, Melhado I, Jirik F, Beutler B (November 1993). "Expression of a TNF inhibitor in transgenic mice". Journal of Immunology. 151 (10): 5699–5703. doi:10.4049/jimmunol.151.10.5699. PMID 7693816. S2CID 10859938.
Braun J, McHugh N, Singh A, Wajdula JS, Sato R (June 2007). "Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly". Rheumatology. 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.
Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. (April 2015). "TNF-alpha inhibitors for ankylosing spondylitis". The Cochrane Database of Systematic Reviews. 2015 (4): CD005468. doi:10.1002/14651858.CD005468.pub2. PMC 11200207. PMID 25887212.
Kim PJ, Lansang RP, Vender R (July 2023). "A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections". Journal of Cutaneous Medicine and Surgery. 27 (4): 358–367. doi:10.1177/12034754231188444. PMC 10486173. PMID 37533141.
Zalevsky J, Secher T, Ezhevsky SA, Janot L, Steed PM, O'Brien C, et al. (August 2007). "Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection". Journal of Immunology. 179 (3): 1872–1883. doi:10.4049/jimmunol.179.3.1872. PMID 17641054.
Madhusudan S, Muthuramalingam SR, Braybrooke JP, Wilner S, Kaur K, Han C, et al. (September 2005). "Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer". Journal of Clinical Oncology. 23 (25): 5950–5959. doi:10.1200/JCO.2005.04.127. PMID 16135466.
Smola MG, Soyer HP, Scharnagl E (October 1991). "Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature". European Journal of Surgical Oncology. 17 (5): 447–453. PMID 1936291.
Houel S, Hilliard M, Yu YQ, McLoughlin N, Martin SM, Rudd PM, et al. (January 2014). "N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality". Analytical Chemistry. 86 (1): 576–584. doi:10.1021/ac402726h. PMID 24308717.
Mukai Y, Nakamura T, Yoshikawa M, Yoshioka Y, Tsunoda S, Nakagawa S, et al. (November 2010). "Solution of the structure of the TNF-TNFR2 complex". Science Signaling. 3 (148): ra83. doi:10.1126/scisignal.2000954. PMID 21081755. S2CID 24226117.
Lamanna WC, Mayer RE, Rupprechter A, Fuchs M, Higel F, Fritsch C, et al. (June 2017). "The structure-function relationship of disulfide bonds in etanercept". Scientific Reports. 7 (1): 3951. Bibcode:2017NatSR...7.3951L. doi:10.1038/s41598-017-04320-5. PMC 5479810. PMID 28638112.
Norman P (January 2017). "Enbrel and etanercept biosimilars: a tale of two patent systems". Pharmaceutical Patent Analyst. 6 (1): 5–7. doi:10.4155/ppa-2016-0043. PMID 28201948.

ncbi.nlm.nih.gov

Peppel K, Crawford D, Beutler B (December 1991). "A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity". The Journal of Experimental Medicine. 174 (6): 1483–1489. doi:10.1084/jem.174.6.1483. PMC 2119031. PMID 1660525.
Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. (April 2015). "TNF-alpha inhibitors for ankylosing spondylitis". The Cochrane Database of Systematic Reviews. 2015 (4): CD005468. doi:10.1002/14651858.CD005468.pub2. PMC 11200207. PMID 25887212.
Kim PJ, Lansang RP, Vender R (July 2023). "A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections". Journal of Cutaneous Medicine and Surgery. 27 (4): 358–367. doi:10.1177/12034754231188444. PMC 10486173. PMID 37533141.
Lamanna WC, Mayer RE, Rupprechter A, Fuchs M, Higel F, Fritsch C, et al. (June 2017). "The structure-function relationship of disulfide bonds in etanercept". Scientific Reports. 7 (1): 3951. Bibcode:2017NatSR...7.3951L. doi:10.1038/s41598-017-04320-5. PMC 5479810. PMID 28638112.

dailymed.nlm.nih.gov

"Enbrel- etanercept solution Enbrel- etanercept kit". DailyMed. Retrieved 17 April 2021.

nytimes.com

Pollock A (23 November 2011). "Amgen's New Enbrel Patent May Undercut Health Care Plan". The New York Times. Retrieved 10 March 2023.

seattletimes.com

"What's behind the whopping price tags on the newest generation of drugs: The story behind the production of Enbrel, Amgen's popular rheumatoid arthritis drug, provides insights as to why bioengineered drugs are so expensive." Carol M. Ostrom, Seattle Times, August 18, 2008

sec.gov

"Portions of the 2010 Financial Report". Sec.gov. Retrieved 2019-06-05.

semanticscholar.org

api.semanticscholar.org

Feldmann M, Maini RN (October 2003). "Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases". Nature Medicine. 9 (10): 1245–1250. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.
Peppel K, Poltorak A, Melhado I, Jirik F, Beutler B (November 1993). "Expression of a TNF inhibitor in transgenic mice". Journal of Immunology. 151 (10): 5699–5703. doi:10.4049/jimmunol.151.10.5699. PMID 7693816. S2CID 10859938.
Mukai Y, Nakamura T, Yoshikawa M, Yoshioka Y, Tsunoda S, Nakagawa S, et al. (November 2010). "Solution of the structure of the TNF-TNFR2 complex". Science Signaling. 3 (148): ra83. doi:10.1126/scisignal.2000954. PMID 21081755. S2CID 24226117.

springer.com

"New hope for survivors of stroke and traumatic brain injury". Springer Select. October 31, 2012. Retrieved November 17, 2018.

squarespace.com

static1.squarespace.com

"2013 Comparative Price Report" (PDF). International Federation of Health Plans. Archived from the original (PDF) on 22 October 2017. Retrieved 24 November 2017.

sskrplaw.com

Kowalczyk L (March 24, 2002). "Lucrative Licensing Deals With Drug, Biotech Firms Are Raising Ethics Issues For Hospitals".

tga.gov.au

"Australian Public Assessment Report for Etanercept" (PDF). Feb 2021.
"AusPAR: Etanercept". Therapeutic Goods Administration (TGA). 25 February 2021. Retrieved 12 June 2021.

uspto.gov

"Patent Terms Extended Under 35 USC §156". Archived from the original on 2010-02-24. Retrieved 2009-12-09.

web.archive.org

"Etera ARTG". Therapeutic Goods Administration (TGA). Archived from the original on 13 June 2021. Retrieved 12 June 2021.
"Rymti ARTG". Therapeutic Goods Administration (TGA). Archived from the original on 13 June 2021. Retrieved 12 June 2021.
"Rymti Summary Basis of Decision". Health Canada. 23 October 2014. Archived from the original on 27 May 2023. Retrieved 10 March 2023.
"Arthritis Drug Effective for Depression in Psoriasis Sufferers". Archived from the original on 2007-10-20. Retrieved 2008-01-10.
"Wyeth and Amgen heighten warning of life-threatening infections on skin drug Enbrel". Archived from the original on 2008-05-05. Retrieved 2008-05-02.
Safety Update on TNF- α Antagonists: Infliximab and Etanercept (PDF). U.S. Food and Drug Administration (FDA). pp. 13–14. Archived from the original (PDF) on 24 September 2015. Retrieved 20 December 2013.
"Etanercept Product Approval Information - Licensing Action 12/2/98". U.S. Food and Drug Administration (FDA). 1 April 2016. Archived from the original on 18 January 2017. Retrieved 4 June 2020.
"2013 Comparative Price Report" (PDF). International Federation of Health Plans. Archived from the original (PDF) on 22 October 2017. Retrieved 24 November 2017.
"Patent Terms Extended Under 35 USC §156". Archived from the original on 2010-02-24. Retrieved 2009-12-09.
"Cipla - Home" (PDF). Cipla.com. Archived from the original (PDF) on 2013-05-01. Retrieved 2019-06-05.

Etanercept (English Wikipedia)

aan.com

abovethelaw.com

archive.today

biopharmadive.com

bostonherald.com

canada.ca

cipla.com

cnn.com

money.cnn.com

doi.org

drugs.com

duke.edu

scholarship.law.duke.edu

dukemednews.org

espacenet.com

worldwide.espacenet.com

europa.eu

ema.europa.eu

ec.europa.eu

fda.gov

accessdata.fda.gov

fda.gov

nctr-crs.fda.gov

funnelback.com

tga-search.clients.funnelback.com

gabionline.net

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

hpfb-dgpsa.ca

dhpp.hpfb-dgpsa.ca

hres.ca

hpr-rps.hres.ca

medicines.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nytimes.com

seattletimes.com

sec.gov

semanticscholar.org

api.semanticscholar.org

springer.com

squarespace.com

static1.squarespace.com

sskrplaw.com

tga.gov.au

uspto.gov

web.archive.org